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The amino acid sequences of mouse monoclonal antibodies have been characterized com- 
pletely by mass spectrometry. Antibodies used in the present study were derived from 
mouse switch variant cell lines that produce four kinds of immunoglobulin Gs (IgGs). The 
amino acid sequences of these antibodies had not been estimated from the corresponding 
DNA sequence, so the sequences of IgGs derived from other strains were used as references 
in this study. Intra- and interchain disulfide bonds of the IgGs were reduced and car- 
boxymethylated and the products were subjected to proteolytic digestion. The existence of 
N-linked oligosaccharides also was taken into account. The capabilities and limitations of 
matrix-assisted laser desorption ionization-time-of-flight mass spectrometry and capillary 
liquid chromatography-electrospray ionization mass spectrometry are discussed in the 
structural characterization of the antibodies. Based on our results, allotypes of the antibodies 
examined are discussed. This study shows that amino acid sequences of proteins, such as 
IgG, can be investigated without information about the corresponding DNA sequence if 
appropriate reference sequences derived from other strains can be used. (J Am Sot Muss 
Spectrom 1996, 7, 707-721 
E lectrospray ionization (ESI) and matrix-assisted laser desorption ionization (MALDI) methods have expanded greatly the analytical applicabil- 
ity of mass spectrometry to the structure investigation 
of biological macromolecules. Not only the determina- 
tion of the molecular weight, but also the characteriza- 
tion of peptides derived from enzymatic digestion of 
the proteins, can be achieved by ES1 and MALDI- 
time-of-flight (TOF) mass spectrometry. A great ad- 
vantage of ES1 and MALDI/TOF mass spectrometry is 
that only a small amount of sample is required to 
determine the molecular weight and the sequence 
characterization of proteins. This is especially true in 
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the case of MALDI, which requires the sample to be 
only in the subpicomole to femtomole range. In addi- 
tion, a large number of peptides can be observed in a 
single MALDI/ TOF mass spectrum of digested pep- 
tides [l, 21. Advances in these techniques have made it 
possible to deal easily with biological macromolecules 
by mass spectrometry. 
Immunoglobulin G (IgG), which has a molecular 
mass of 150 ku, and its fragments have been analyzed 
by electrospray ionization mass spectrometry (ESI-MS) 
[3-61 and matrix-assisted laser desorption ionization- 
time-of-flight/ mass spectrometry (MALDI/TOF-MS) 
[7]. Peptide mapping also has been performed for the 
characterization of a recombinant humanized mono- 
clonal antibody by ESI-MS [Bl or MALDI/TOF-MS, 
liquid secondary ionization mass spectrometry (LSI- 
MS), and ESI-MS [9]. In these studies, it was impossi- 
ble to detect all of the molecular masses of digested 
peptides by LC/ESI-MS or MALDI/TOF-MS measure- 
ment. Recently, Roberts et al. [lo] reported complete 
structural characterization of a recombinant, reshaped 
human monoclonal antibody by mass spectrometry. 
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. 
These studies were performed for the structure verifi- 
cation of recombinant products that included the struc- 
ture of the N-linked sugar chain. In the present work 
we have used mass spectrometry successfully to char- 
acterize the amino acid sequences of IgGs whose amino 
acid sequences had not been estimated from the corre- 
sponding DNA sequence. 
IgG consists of two identical heavy chains and two 
identical light chains. The heavy chains.are composed 
of four homologous units, V, (variable region of the 
heavy chain), C nl, C ,, 2, and C n 3 (constant regions of 
the heavy chain), whereas the light chains are divided 
into two homologous units, V, (variable region of the 
light chain) and C, (constant region of the light chain). 
The C,2 domain has an Asn-linked oligosaccharide. 
The amino acid sequences of the variable region that 
recognizes the antigen always have been analyzed 
carefully. By contrast, little has been done on the 
amino acid sequences of the constant region of IgG, 
because the amino acid sequences of the constant re- 
gion are believed to be highly homologous. The exis- 
tence of allotypic markers in the heavy chain long has 
been known and the immunological significance of 
allotype is well documented [ll]. Allotypic markers 
with specific amino acid substitutions traditionally 
have been characterized by using antiallotypic sera. 
However, specific antiallotypic sera are not always 
obtainable. More importantly, allotypic markers that 
happen to correspond to amino acid residues are not 
always located on the surface of the protein molecules 
and would not be detected by the conventional anti- 
sera, because the sera would not be able to interact and 
detect the specific amino acid residues. 
The IgGs used in the present mass spectrometric 
analyses belong to a switch variant family and have a 
number of interesting features. A switch variant family 
that produces mouse antidansyl monoclonal antibodies 
has been generated by Dangl et al. [12]. This family of 
mouse switch variant antibodies produced by C3H/SW 
strain cells recognizes the identical antigen-dansyl- 
lysine-and contains four subclasses. Hereafter, these 
antidansyl antibodies will simply be referred to as the 
four subclasses IgGl, IgGZa, IgG2b, and IgGZa(s). 
IgG2a(s) is an interesting short-chain IgG2a variant, in 
which the entire C,l domain is deleted from the 
normal IgG2a [13]. A fascinating feature of these anti- 
bodies is that they possess the identical V,, V,, and 
C, in conjunction with different heavy chain constant 
regions, according to the definition of switch variant. 
However, little attempt has been made to identify the 
amino acid sequences of V,, V,, and CL regions of 
these antibodies or to determine the sequences of the 
constant regions of the heavy chain because of the 
large molecular weights of the antibodies. This set of 
switch variant antibodies provides an interesting op- 
portunity to apply mass spectrometry to a number of 
problems of immunochemical interest; it is significant 
just to characterize the structure of all these antibodies, 
which include the N-linked sugar chain. DNA se- 
quence information for the constant region of the heavy 
chain was not obtained for each switch variant anti- 
body. Therefore, amino acid sequences of other IgGs 
that belong to the same subclass but are derived from 
different mouse strains are used as references in this 
study. We selected several sequences of IgGs that 
originated from another close strain for reference 
sequences. 
Establishment of the amino acid sequences of these 
switch variant antibodies is expected to enable us to 
characterize the structure of the allotypic marker(s) 
that exist in the heavy chain. Detection of amino acid 
substitution(s) compared to the reference sequences of 
other IgGs that belong to the other allotype would lead 
to the allotypic marker(s). Mouse IgG2a produced by 
CSH/SW strain, which belongs to haplotype-j strain, 
was classified as allotype-a, but it is now classified as 
allotype-j, because of its negative response to a con- 
ventional antiserum [141. Only two kinds of guinea pig 
antisera can differentiate allotype-j and allotype-a of 
IgG2a, and IgG2a investigated in this study has been 
classified into allotype-j by the serological criteria. 
Mouse IgGs of other subclasses produced by haplo- 
type-j strain can be grouped into allotype-j, too, but no 
difference from allotype-a has been detected by any 
antiserum. Therefore, the amino acid sequences of IgGs 
that originate from haplotype-a strain and haplotype-j 
strain, that is, of IgGs that carry allotype-a and allo- 
type-j, are expected to be quite similar. However, 
analyses of the amino acid sequences have not been 
carried out. 
In this article we report the results of mass spectro- 
metric characterization of the structure of mouse switch 
variant antibodies. Identification of the variable re- 
gions and characterization of the constant regions was 
achieved as was posttranslational modification. On the 
basis of the results obtained, the allotype of the switch 
variant antibodies is discussed. Another purpose of the 
present study is to discuss the characteristics of several 
mass spectrometric techniques for the identification of 
the structure of biological macromolecules with a 
molecular weight on the order of 150 ku. The capa- 
bilities and limitations of MALDI/TOF-MS and capil- 
lary LC/ESI-MS for peptide mapping of IgGs are 
compared. 
The strategy we used is as follows. First, the molec- 
ular weights of IgGl, IgG2a, IgG2b, and IgG2a(s) were 
determined by MALDI/TOF-MS. MALDI/TOF-MS 
peptide mapping then was carried out. The amino acid 
sequences of IgGs produced by other mouse strains, 
which included haplotype-a, were used as references. 
Capillary LC/ESI-MS also was applied to complete the 
assignment of the observed mass values to the pep- 
tides obtained by the enzymatic digestion. All peptides 
with unexpected molecular weights were isolated by 
high-performance liquid chromatography (HPLC) and 
subjected to amino acid sequence analyses. Thus, a 
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structural characterization of the mouse switch variant vents consisted of (A) 0.1% aqueous TFA and (B) 
antibodies was accomplished. Immunochemical impli- acetonitrile:water 9:l with 0.095% TFA. A linear gradi- 
cations of the results obtained in this study in terms of ent elution of 100% (A>35% (A) was performed for the 
the allotype of IgGs used are discussed. isolation of peptides. 
Experimental 
Materials. Dithiothreitol, iodoacetic acid, lysyl-endo- 
peptidase, and trifluoroacetic acid (TFA) were pur- 
chased from Wako Pure Chemical Industries (Osaka, 
Japan). Staphylococcus uureus V8 protease was pur- 
chased from ICN ImmunoBiologicals (Costa Mesa, CA), 
chymotrypsin was purchased from Sigma (St. Louis, 
MO), and acetonitrile was purchased from Nacalai 
Tesque (Kyoto, Japan). 
Preparation and purification of IgGs. The antidansyl 
switch variants IgGl, IgG2a, IgG2b, and IgG2a(s) that 
originate from C3H/SW mice (haplotype-j) were pr@ 
duced by cultivation of hybridoma cells and purifica- 
tion in the same manner as reported previously [15]. 
Reduction and S-curboxymefhylation. Lyophilized IgG 
(550 pg) was dissolved in 500 I.LL of 0.5-M Tris-HCl 
buffer (pH 8.1) that contained 6-M guanidine and 
2-mM ethylenediaminetetraacetic acid (EDTA). After 
addition of 900 pg of dithiothreitol, the mixture was 
bubbled with nitrogen, heated at 50°C for 3 h, and 
allowed to stand overnight at room temperature. To 
this solution 2.2 mg of iodoacetic acid was added; the 
pH of the solution was kept at 8.0-8.5 by using 0.1-N 
NaOH. After 30 min, the protein was dialyzed against 
50-mM ammonium bicarbonate buffer at 4 “C, and 
lyophilized. 
ProteoZytic digestion of IgGs. Lysyl-endopeptidase di- 
gestion of reduced and carboxymethylated (RCM) IgG 
was performed under the conditions of a 2OO:l molar 
ratio of substrate to enzyme in 50-n&l ammonium 
bicarbonate buffer (pH 8.4) at 37°C for 18 h. V8 pm 
tease digestion of RCM-IgG was performed under the 
conditions of a 1OO:l molar ratio of substrate to en- 
zyme in 50-mM ammonium bicarbonate buffer (pH 
7.9) at 37°C for 15 h. Chymotryptic digestion of a 
fractionated peptide was performed under the condi- 
tions of a 5O:l molar ratio of substrate to enzyme in 
50-n-M ammonium bicarbonate buffer (pH 7.9) at 37 “C 
for 4 h. The hydrolysis was stopped by addition of 5% 
acetic acid and then the solution was lyophilized. 
Matrix-assisted laser desorption mass spectromety. All 
MALDI spectra were obtained by using a Shirnadzu- 
Kratos KOMPACT MALDI-III time-of-flight mass 
spectrometer (Manchester, UK), which had a 337~nm 
nitrogen laser. The analyzer was used in the linear or 
reflector mode, at an accelerating voltage of 20 kV. 
Samples were dissolved in 0.1% TFA, and 0.5 PL of 
the sample solution was deposited on a stainless sam- 
ple slide. After drying with air, 0.5 PL of .matrix 
solution [2,5-dihydroxybenzoic acid (DHBA) or 3,5-di- 
methoxy-4-hydroxycinnamic acid (sinapinic acid)/ 2- 
(4-hydroxyphenylazo)benzoic acid (HABA) (20/l), in 
0.1% TFA: 50% ethanol (EtOH)] was added to the 
sample spot. For 1oW molecular weight peptides (MW 
< 40001, DHBA was applied as the matrix. For high 
molecular weight peptides (MW > 20001, the sinapinic 
acid:HABA (2O:l) mixture was applied as the matrix. 
The sample slide was air-dried prior to transfer into 
the source of the mass spectrometer. The MALDI mass 
spectra were calibrated externally by using calibrant 
proteins (bovine serum albumin, lysozyme, or bovine 
insulin). A more accurate mass assignment of prote- 
olytic fragments was achieved by using an identified 
peptide fragment and a matrix peak as internal cali- 
brants. 
Liquid chromatography-electrospray ionization mass spec- 
trometry. The capillary HPLC system consisted of an 
ABI 140B dual syringe solvent delivery system (Ap- 
plied Biosystems, Inc., Foster City, CA). A Kontron 
(Milano, Italy) 433 capillary detector was set at 210 run. 
The solvents consisted of (A) 0.1% aqueous TFA and 
(B) acetonitrile:water 9:l with 0.095% TFA. A linear 
gradient elution of 100% (A)35% (A) was performed 
for the isolation of peptides by a Vydac Cl8 capillary 
column packed by LC Packings (San Francisco, CA). 
The solvents were mixed and split by an Acurate unit 
(LC Packings) and the flow rate was reduced to 2.7 
pL/rnin. Electrospray ionization mass spectrometry 
(ESI-MS) was performed on a Finnigan-MAT (San Jose, 
CA) TSQ700 equipped with an Analytica electrospray 
ion source (Analytica of Branford, Branford, CT). Pro- 
teolytic peptides (N 30 pmol) were injected into the 
capillary HPLC system and then introduced into the 
mass spectrometer. 
Reversed phase (RP) HPLC. A conventional HPLC sys- 
tern that consists of two Jasco (Tokyo, Japan) 880-PU 
pumps was used. A Jasco 870 UV detector was set at 
210 run. Isolation of proteolytic peptides for fast-atom 
bombardment (FAB) mass spectrometry and amino 
acid sequence analyses was performed on a Vydac 
(Hesperia, CA) Cl8 column (4.6 x 250 mm). The sol- 
Fast-atom bombardment mass spectromety. Fast-atom 
bombardment mass spectra were obtained by the first 
mass spectrometer of a JEOL (Tokyo, Japan) I-IX/ llO/ 
HXllO tandem mass spectrometer. The sample was 
dissolved in 1-N HCl and deposited on a stainless 
sample target. After addition of glycerol:thioglycerol 
(1:l) matrix, the sample target was introduced into the 
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mass spectrometer. All spectra were obtained at a 
resolution of 3000 or 2000, which enabled the detection 
of each peak with unit mass resolution. 
Edman sequence analysis. Edman sequence analysis 
was performed on a Shimadzu (Kyoto, Japan) PPSQ-10 
sequencer. 
Peptide assignment. Molecular weights of the peptides 
were attributed to the sequences of the reference IgGs 
by using MacBioSpec (PESciex, Ontario, Canada). 
Results and Discussion 
Molecular Weight Determination by MALDl/ 
TOF-MS 
Molecular weights of IgGl, IgG2a, IgG2b, and IgG2a(s) 
were determined by MALDI/TOF-MS. Figure 1 shows 
MALDI/TOF mass spectra of the four mouse im- 
munoglobulins. In the case of IgGl, IgG2a, and IgG2b, 
the light chains and the heavy chains are bound with 
disulfide bonds. By contrast, no covalent bond exists 
between the light chains and the heavy chains in 
IgG2a(s), in which the entire C,l domain is deleted 
1131. The IgGl, IgG2a, and IgGP antibodies gave 
molecular peaks at m/z 150,188, 151347, and 152,156, 
respectively, whereas two molecular peaks were ob- 
served at m/z 24,285 and 83,612 in the case of IgG2a(s). 
There are no expected sequences for these IgGs from 
the corresponding DNA sequences, but sequences of 
IgGs derived from another strain are used as refer- 
ences and “expected” mass values are calculated. The 
method of selection for reference sequences for these 
IgGs is described in the following text. The “expected” 
mass values are 149,964 (IgGl), 151,700 (IgG2a), 152238 
(IgG2b), 24,128 [light chain for IgG2a(s)], and 83,443 
[heavy chain for IgG2a(sl], with the assumption that 
the major component of the N-linked oligosaccharides 
of these antibodies is type F or G with a molecular 
weight of 1625.5 (average molecular weight) [16]; see 
Figures 1 and 2. The mass difference between observed 
and “expected” mass values is within m 350 u in 
MALDI/TOF-MS of every subclass. 
Bovine serum albumin was used as a calibrant to 
obtain the MALDI/TOF mass spectra in Figure 1, 
although the molecular weight of IgG is much larger 
than that of bovine serum albumin. This discrepancy 
results in relatively low accuracy for the determination 
of the molecular weights of IgGs. It has been reported 
that heterogeneous sugar chains are linked to Asn297H 
of IgGs [16]. In addition, the existence of adduct ions 
of matrices to the molecular ion must be taken into 
accormt in MALDI/TOF-MS of proteins with large 
molecular weight. Accordingly, it is difficult to deter- 
mine the molecular weight of IgGs exactly. A result of 
MALDI/TOF-MS analyses of intact molecules of the 
switch variants suggests that sugar chains are linked to 
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Figure 1. h4ALDILTOF mass spectra of (a) IgGl, (b) IgG2a, (c) 
IgGZb, and (d) IgG2a(s). 
IgG molecule, as expected, and their average molecu- 
lar weights are N 3 ku. 
Reference Sequences for the Study 
When peptide mappings of large proteins are carried 
out by mass spectrometry, information on amino acid 
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Figure 2. MALDI/TOF mass spectra of the lysyl-endopeptidase digest of RCM IgGl. (a) DHBA 
matrix; (b) sinapinic acid: HABA (2O:l) matrix. Structures of oligosaccharides linked at Asn297I-i are 
indicated at the top of the figure. Symbols: G, galactose; M, mannose; F, fucose; GN, N-acetylglu- 
cosamine. The complete structure of H also is given. 
sequences is necessary as a reference, because it is 
difficult to determine the unknown amino acid se- 
quence by mass spectrometry only. Identical amino 
acid sequences for the V, and V, regions were used as 
references in the present study [171, because these IgGs 
belong to a switch variant family (The definition of 
switch variant is that they have the identical variable 
regions in their genetic sequences. The amino acid 
sequence of the V, region of the switch variant anti- 
body IgGl used in the present study was given by 
Dangl [ 171. The sequence of the V, region of the switch 
variant IgGl was kindly provided by Professor L. A. 
Herzenberg, Stanford University, and Dr. V. T. Oi, Bec- 
ton Dickinson Immunocytometry Systems. Sequence 
data of the C, region were reported for mouse 
myeloma protein MOPC21 [18]. These sequence data 
were used as references for V,, V,, and C, regions in 
all switch variant antibodies in this study.) The identi- 
cal sequence for the C, domain also was used as a 
reference for these IgGs, because of the belief that only 
one sequence exists that corresponds to the C, domain 
in the light chain classified into K subgroups in the 
case of mouse IgG. Selection of an appropriate refer- 
ence sequence for the other constant region of each IgG 
in this study is significant because no information on 
the DNA sequence has been established for Cnl, C,2, 
and C,3 regions of these IgGs. Several different se- 
quences have been reported for the constant region of 
the heavy chain of mouse IgGs that belong to the same 
subclass [18-261 but are derived from another mouse 
strain. 
IgGl 
For the sequences of the constant region of the heavy 
chain, attention was paid to two sequences: sequence 
(a) reported by Honjo et al. [181 and sequence (b) 
reported by Adetugbo et al. 1191. These two sequences 
are highly homologous, but a small number of differ- 
ences do exist. No description of the allotypes of the 
IgGl studied was mentioned in these papers. We paid 
attention to both sequences because there are no proper 
criteria to justify selection of one amino acid sequence 
as reference. 
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hJALDI/TOF-MS peptide mapping. Figure 2 shows 
MALDI/TOF mass spectra of the peptides derived 
from the lysyl-endopeptidase digestion of RCM IgGl. 
To observe as many molecular ion peaks as possible, 
two kinds of matrices-DHBA and a mixture of sinap- 
inic acid: HABA (20:1)-were tested for the analysis. 
Addition of 5% HABA to sinapinic acid increases the 
number of the peptides that can be detected in a single 
MALDI spectrum, compared to the matrix of sinapinic 
acid alone, with respect to detection of components of 
higher molecular weight. As Figure 2a and b shows, a 
considerable number of protonated molecular ions of 
the peptides were observed. The results are summa- 
rized in Table 1. The specificity of the enzymes used 
for the digestion of RCM IgGl was taken into account 
to interpret the MALDI/TOF mass spectra. For exam- 
ple, an intense peak at m/z 2810.9 in Figure 2b, which 
also was observed in Figure 2a at m/z 2808.2, was 
assigned to the protonated molecular ion of 20H-43H. 
(The numbering system used in the present article for 
the constant region is based on human myeloma pro- 
tein Eu for the heavy chain [27] and mouse myeloma 
protein MOPC21 for the light chain [201. Amino acid 
residues in the heavy and light chains are identified by 
H and L, respectively, e.g., Asn297I-I and Trp35L, or 
297I-I and 35L.) 
The structure of the N-linked oligosaccharides at 
Asn297H is known to be heterogeneous. In the case of 
IgGl used in the present study, the structures of the 
N-linked oligosaccharides were determined previ- 
ously, as shown in Figure 2 [16]. Three peaks were 
observed at m/z 7269.5, 7427.4, and 7588.9 in the 
MALDI/TOF mass spectrum of the lysyl-endopepti- 
dase digest (Figure 2b), and these peaks are the molec- 
ular ions of glycopeptide 269H-317I-I. Similarly, other 
triplet peaks also were observed at m/z 8371.8,8533.1, 
and 8689.0, which are the molecular ions of glycopep- 
tide 259H-317H. The observed mass values were con- 
sistent with the reported structure of the oligosaccha- 
rides shown in Figure 2. 
It was not possible to assign an intense peak ob- 
served in Figure 2b at m/z 6559.7 to any part of either 
sequence (a) or (b). It was decided that the sequence of 
this peptide should be determined. 
MALDI/TOF-MS peptide mapping of the lysyl- 
endopeptidase digest of RCM IgGl indicated that about 
70% of the amino acid sequences of IgGl are identical 
to the reference sequences and that sequence (a) re- 
ported by Honjo et al. [18] is more appropriate than 
sequence (b) as a reference for the constant region of 
the heavy chain. Hence sequence (a) was used as a 
reference sequence for IgGl. Some parts of the se- 
quences could not be confirmed by the MALDI/ TOF- 
MS peptide mapping, possibly because too many pep- 
tides were produced by the lysyl-endopeptidase diges- 
tion of RCM IgGl. It is possible also that amino acid 
substitutions exist in the sequence of IgGl that origi- 
nates from haplotype-j mice. The existence of amino 
acid substitutions at Asp399H, Asp401H, and Ile406H 
in IgGl that were found in a previous NMR study [28] 
has been confirmed by this peptide mapping. 
To establish the complete amino acid sequences of 
IgGl, digestion with V8 protease also was utilized for 
MALDI/TOF-MS peptide mapping. Table 2 summa- 
rizes the observed mass values in the MALDI/TOF 
mass spectra of the peptides produced by the digestion 
of RCM IgGl with V8 protease. All of the sequences of 
the light chain of IgGl that originate from haplotype-j 
mice were identified as identical to reference sequence 
(a), but only 87% of the sequence of the heavy chain 
proved to be identical to the reference sequence, even 
though two kinds of enzymes were used for the pep- 
tide mapping. At this stage, the sequences of small 
peptides at the N- and the C-terminus of the heavy 
chain and the sequence of Gly148H-Lys210H could not 
be confirmed. 
K/E%MS peptide mapping. Capillary LC/ESI-MS 
analysis was applied to the lysyl-endopeptidase digest 
of RCM IgGl to complete the assignment of the ob- 
served mass values to the peptides. Figure 3 shows the 
UV chromatogram of capillary I-IPLC of the lysyl- 
endopeptidase digest. Protonated molecular masses 
calculated by deconvolution of the observed ions in 
LC/ ESI-MS analysis of the lysyl-endopeptidase digest 
of RCM IgGl also are summarized in Table 1. The 
investigation of the sequences of the C- and N-terminal 
parts and of the other unidentified regions in IgGl will 
be discussed in the following text. 
By LC/ESI-MS analyses, the C-terminal peptide of 
RCM IgGl that was not observed in MALDI/TOF-MS 
spectra could be identified. Both of the C-terminal 
peptides Ser440H-Gly446H and Ser440H-Lys446AH 
were found in peaks 8 and 6, respectively, and it was 
proved that the C-terminal Lys residue is missing in 
some proportion of IgGl in this study. The N-terminal 
part of the heavy chain (GlulH-Glu6H) and the region 
of Gly148H-Glu196H were not confirmed by LC/ESI- 
MS analysis of the lysyl-endopeptidase digest of RCM 
IgGl. Consequently, the digest of V8 protease also was 
applied to capillary LC/ESI-MS analysis. In the LC/ESI 
mass spectrum, molecular peaks of the N-terminal 
peptide GlulH-Glu6H were observed at m/z 373.8 
(2 + 1 and 746.2 (1 + 1, but no molecular ion of the 
peptide around the region of Gly148H-Glu196H could 
be observed. 
An ion at m/z 1640.7 was observed in peak 62 by 
capillary LC/ESI-MS analysis (Figure 3). This ion was 
estimated to be a 4+ peptide ion and its molecular 
weight was calculated by deconvolution to be 6558.8. 
It is possible that the 4 + ion at m/z 1640.7 in Figure 3 
and the ion at m/z 6559.7 in Figure 2b were derived 
from the same peptide. We tentatively assigned this 
peptide to Gly148H-Lys210H, because this was the 
only peptide whose molecular weight had not been 
confirmed at this stage. The molecular weight of the 
peptide 148H-210H was calculated to be 6525.2 (aver- 
age mass) from the reference sequence (a) [18] and the 
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Table 1. Observed mass values in MALDI/TOF-MS and capillary LC/ESI-MS of the lysyl-endopoptidase digest of 
RCM IgGl with the attribution of the mass numbers to the previously reported sequence (a) [16-l& 281 
position 
(M + H)+ LC-MS [M+HI+ expected 
MALDI peak LC/MS expect. mono- 
Hor LB Fromb Tab obs.C Amd no.’ obs.’ averagea Amd isotooich Am’ Comment 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
1 39 4921.4 
1 45 n.d.i 
1 74 n.d. 
40 45 n.d. 
46 50 648.8 
51 74 2519.9 
51 103 n.d. 
75 103 3222.6 
75 107 3705.6 
104 107 n.d. 
108 142 3731.3 
143 147 n.d. 
148 149 n.d. 
150 169 2251.5 
170 183 n.d. 
170 207 n.d. 
184 199 2042.5 
184 199 2063.8 
200 207 834.0 
208 214 927.3 
208 214 949.5 
1 3 n.d. 
4 19 n.d. 
20 43 2808.2 
20 43 2830.3 
44 528 1315.2 
44 528 1337.2 
52c 64 1470.3 
52C 75 n.d. 
65 75 1281.7 
65 119 n.d. 
76 119 5385.7 
120 147 n.d. 
148 210 n.d. 
211 214 n.d. 
215 225 n.d. 
215 246 3169.9 
215 246 3190.5 
215 317 n.d. 
215 317 n.d. 
215 317 n.d. 
247 248 n.d. 
249 258 n.d. 
259 268 1122.0 
259 317 8371.8 
259 317 8533.1 
259 317 8689.0 
269 317 7269.5 
269 317 7427.4 
269 317 7588.9 
0.9 
1 
-1.1 
0.2 
0.0 
-0.6 
0.1 
1.2 
0.4 
-0.3 
1 .o 
- 0.7 
-0.5 
-0.9 
-0.8 
-0.3 
-0.3 
1.7 
-0.7 
- 1.4 
1.2 
-0.2 
-0.3 
1.8 
0.9 
-5.3 
1.8 
2.4 
-3.1 
48 
47 
51 
61 
28 
32 
53 
46 
18 
61 
11 
29 
30 
33 
12 
12 
13 
10 
21 
54 
54 
36 
17 
31 
19 
57 
59 
44 
7 
39 
48 
64 
64 
64 
37 
29 
58 
58 
58 
56 
56 
56 
4919.8 4920.5 
5513.0 5414.5 
8642.8 8647.6 
3.1 613.7 
649.2 649.9 
2519.2 2519.7 
5722.0 5723.3 
3221.6 3222.6 
n.d. 3706.2 
502.3 502.6 
3729.4 3731.2 
588.3 588.7 
n.d. 333.4 
2250.0 2250.4 
1535.3 1535.7 
4371.5 4372.8 
2041.6 2042.1 
n.d. 2064.1 
832.3 833.0 
927.2 928.0 
n.d. 950.0 
n.d. 375.5 
1545.1 1546.7 
2807.8 2809.1 
n.d. 2831 .l 
1315.5 1315.5 
n.d. 1337.5 
1467.5 1468.6 
2731 .O 2731.9 
1281.9 1282.4 
6647.8 6650.5 
5386.6 5387.1 
2862.4 2863.3 
n.d. 6526.2 
489.4 489.6 
1107.9 1107.3 
3166.9 3168.7 
n.d. 3190.7 
12823.4 12827.3 
12995.0 12989.5 
13115.4 13151.6 
n.d. 244.3 
1100.4 1101.3 
1120.8 1121.3 
8366.8 8370.0 
8528.2 8532.2 
8990.8 8694.3 
7264.0 7267.7 
7425.0 7429.8 
7592.5 7592.0 
-0.7 
-0.7 
-1.5 
-0.6 
-0.6 
-0.5 
-1.3 
- 1 .o 
-0.3 
-1.8 
-0.4 
-0.3’ 
-0.4 
-1.3 
-0.5 
-0.7 
-0.8 
-1.6 
-1.3 
0.0 
-1.1 
-0.9 
-0.5 
-2.7 
-0.5 
-0.9 
-0.2 
0.6 
-1.8 
-3.9 
5.5 
- 36.2 
-0.9 
-0.5 
-3.2 
-3.9 
-3.5 
-3.7 
-4.8 
0.5 
4917.4 
5511.7 
8641.4 
613.3 
649.4 
2518.2 
5719.7 
3220.5 
3703.8 
502.3 
3728.8 
588.3 
333.2 
2249.0 
1534.7 
4370.0 
2040.8 
2064.8 
832.5 
927.4 
949.4 
375.2 
1545.8 
2807.2 
2829.2 
1314.7 
1336.7 
1467.7 
2730.3 
1281.7 
6646.3 
5383.6 
2861.4 
6522.2 
489.3 
1106.5 
3166.5 
3198.5 
12819.1 
12981.1 
13143.2 
244.2 
1100.7 
1120.6 
8364.8 
8526.9 
8688.9 
7263.3 
7425.3 
7587.4 
2.4 
2.8 
6.2 
-0.2 
-0.2 
1.0 
2.3 
1.1 
0.0 
0.6 
0.0 
1.0 
0.6 
1.5 
0.8 
-Nak 
-0.2 
-0.2 
-Na 
-0.7 
0.6 
0.8 
-0.2 
0.7 
0.3 
1.5 
3.0 
1 .o 
0.1 
1.4 
0.4 
4.3 Sugar-linked’ 
13.9 Sugar-linked 
-27.8 Sugar-linked 
-0.3 
0.2 
2.0 
1.3 
1.9 
0.8 
-0.3 
5.1 
+Na 
+Na 
Sugar-linked 
Sugar-linked 
Sugar-linked 
Sugar-linked 
Sugar-linked 
Sugar-linked 
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Table 1. (Continued). 
(M + HI+ LC-MS [M+HI+ 
position MALDI peak LC/MS expect. expected 
H or LB Fromb Tab ohs.= Amd no.B ohs.’ average9 Amd monoisotopich Am’ Comment 
H 318 320 n.d. 6 423.3 423.5 -0.2 423.2 0.1 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
- 
321 334 
321 334 
335 338 
339 344 
341 344 
345 355 
356 360 
356 362 
363 392 
393 409 
393 439 
410 414 
415 439 
440 446 
440 4468 
1561.5 
1583.9 
n.d. 
n.d. 
457.4 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
2907.4 
n.d. 
n.d. 
6559.7 
-0.3 27 
0.1 
2 
-0.2 
23 
3 
20 
66 
34 
45 
9 
-0.7 35 
a 
6 
62 
1560.2 
n.d. 
448.2 
n.d. 
n.d. 
1210.4 
606.3 
850.4 
3621 .l 
i 979.8 
5452.2 
601.3 
2906.8 
684.4 
812.3 
6559.8 
1561.8 
1583.8 
448.5 
686.8 
457.6 
1211.5 
606.7 
850.0 
3622.0 
1981.2 
5453.0 
601.7 
2908. i 
684.7 
al 2.9 
-1.6 
-0.3 
- 1 .o 
-0.4 
0.4 
-0.9 
-1.4 
-0.8 
-0.4 
-1.3 
-0.3 
-0.6 
1560.8 
1562.8 
448.3 
686.4 
457.3 
1210.7 
606.3 
849.4 
3619.6 
1979.9 
5449.5 
601.4 
2906.3 
684.4 
812.4 
-0.6 
+Na 
-0.1 
-0.3 
0.0 
1.0 
1.5 
-0.1 
2.7 
-0.1 
0.5 
0.0 
-0.1 
148H-210Hm 
‘Heavy chain (H) or light chain (L). 
bThe position of the amino acid residue. 
‘Observed mass value in MALDI/TOF-MS. 
“Mass difkrence between the observed and expected average mass values. 
“Peak number in Figure 3. 
‘Observed mass value in LC/ESI-MS calculated by deconvolution. 
OExpected average mass value. 
hExpected monoisotopic mass value. 
iMass difference between the observed and expected monoisotopic mass values. 
‘Not detected. 
kSodium adduct. 
‘Sugar-linked peptide. 
mEstimated attribution. 
mass difference between the observed and the theoreti- 
cal values based on the reference sequence was about 
34 u. Accordingly, it was concluded that substitution 
of amino acid(s) exists in this region. 
Characterization of the region of 148H-21OH. The pep- 
tide Gly148H-Lys210H was isolated by RI’-HPLC, and 
digested with chymotrypsin. The digest was subjected 
to LC/ESI-MS analysis. Figure 4 shows a UV chro- 
matogram of chymotryptic digest of the peptide 
Gly148H-Lys210H. The protonated molecular masses 
of the peptides Gly148H-Trp158H and Asn159H- 
TyrlBOH, observed in EST-MS, were determined by 
deconvolution to be 1295.7 and 2180.8, respectively. 
These mass values are in good agreement with the 
expected mass values based on the reference sequences 
[18, 191. It is possible that the peak at 45.5 n-tin in 
Figure 4 is due to the peptide ThrKNH-Lys210H, but 
the molecular mass obtained for this peptide by decon- 
volution is 33.6 u greater than the calculated value 
based on both of the reference sequences [18, 191. This 
mass difference can be brought about by a single 
amino acid substitution, such as Phe for Leu, Met for 
Pro, or Tyr for Glu. To determine the sequence of this 
peptide, it was subjected to amino acid sequence anal- 
ysis after isolation by RI’-HPLC. Thr and Trp were 
found instead of Pro193H and Arg194H, respectively. 
It is of interest that the triplet codon for the found 
amino acid residues and those in the reference se- 
quences are quite similar. The triplet codon for Thr is 
ACX (X is U, C, A, or G), whereas that for Pro is CCX. 
The difference between these two codons is only the 
first letter in the triplet. The difference in the triplet 
codon for Trp and Arg is similar. The theoretical mass 
value of the protonated molecular ion of this peptide 
can be calculated to be 3119.5 (average mass), which is 
in good agreement with the observed average mass 
value in LC/ESI-MS. The revised sequence of this 
peptide was confirmed by FAB mass spectrometry 
analysis, where the detection of monoisotopic proto- 
nated molecular ions was via a sector-type instrument. 
Thus the primarystructure of IgGl was determined as 
shown in Figure 5. 
lgG2a, lgG2a(s), and lgG2b 
Mass spectrometric characterizations of the amino acid 
sequences for IgG2a, IgG2a(s), and IgG2b were carried 
out also. Three sequences have been reported for the 
constant region of the heavy chain of IgG2a that car- 
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Table 2. Observed mass values in h4ALDI/TOF-MS of the Staphylococcus aureus V8 protease digest of RCM IgGl, with the attribution 
of the mass numbers of the previously reported sequence (a) [16-18,281. 
H or La 
Position 
Fromb Tab 
[M + HI+ 
ohs.= 
[M + HI+ 
expecLd Ame Comment R or L’ 
L 1 
L 1 
L 106 
L 124 
L 124 
L 155 
L 186 
L 188 
L 196 
H 1 
H 7 
H 43 
H 51 
H 51 
H 62 
H 86 
H 153 
H 196A 
H 237 
H 237 
H 237 
H 273 
H 284 
H 284 
H 295 
H 295 
H 295 
H 295 
H 306 
H 306 
H 319 
H 319 
H 334 
H 334 
H 357 
H 357 
H 381 
H 390 
H 419 
H 419 
H 431 
H 431 
H 439 
H 439 
79 9.232.8 9,231.4 
105 12.104.2 12.092.6 
123 1.886.5 1.887.4 
154 3.489.0 3,489.g 
185 6,980.7 6,980.7 
185 3,509.5 3,509.E 
195 1.359.3 1.360.4 
195 1,067.3 1.068.1 
214 2,178.g 2,179.4 
6 n.d.s 746.8 
42 3.837.2 3,837.2 
50 931.8 932.1 
61 1.665.2 1,665.E 
61 1.689.2 1,687.E 
85 n.d. 3,228.7 
152 n.d. 7.122.1 
196 n.d. 4.476.9 
236 n.d. 3.992.6 
272 3987.7 3.987.7 
272 4,009.l 4.010.7 
283 5,338.2 5.340.2 
293 2.519.7 2.519.7 
294 1,295.5 1.296.4 
294 1.317.5 1.318.4 
305 2,747.7 2.747.8 
305 2.763.8 2.763.8 
305 2,908.E 2.909.9 
305 3.070.9 3.072.0 
318 1.582.3 1,581.E 
318 1.603.9 1,603.E 
333 1.708.6 1.709.0 
333 1.730.8 1,731.0 
356 2,565.4 2.566.1 
356 2.588.4 2,588.1 
375 2,263.4 2.263.4 
380 2.822.2 2.820.1 
389 1,116.6 1.116.2 
418 3.486.5 3.485.7 
430 1.336.7 1,337.5 
438 2.263.4 2,263.6 
438 944.4 945.0 
438 966.1 967.0 
446 n.d. 942.0 
446A n.d. 1,070.o 
1.4 L 
11.6 L 
-0.9 R 
-0.9 R. L 
0.0 L 
-0.3 R 
-1.1 R 
-0.8 R 
-0.5 R 
0.0 
-0.3 
-0.6 
1.4 
0.0 
-1.6 
-2.0 
0.0 
-0.9 
-0.9 
-0.1 
0.0 
-1.1 
-1.1 
0.5 
0.1 
-0.4 
-0.2 
-0.7 
0.3 
0.0 
2.1 
0.4 
0.8 
-0.8 
-0.2 
-0.6 
-0.9 
-Nab 
+Na 
+Na 
Sugar-linked’ 
Sugar-Linked 
Sugar-Linked 
Sugar-Linked 
-Na 
+Na 
+Na 
j 
j 
+Na 
R, L 
R 
R 
R 
R L 
R 
L 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R 
R, L 
R. L 
R 
R. L 
R 
R. L 
R 
R 
‘Heavy chain (H) or light chain (L). 
bThe position of the amino acid residue. 
‘Observed mass value. 
dExpected average mass value. 
‘Mass difbrence between the observed and expected values. 
‘Analyzed mode; reflector (R) or linear (L). 
gNot detected. 
hSodium adduct. 
fSugar-linked peptide. 
‘Mass value that can be assigned to two positions. 
ries allotype-a [21-241. In LC/ESI-MS of the lysyl- 
endopeptidase digest of RCM IgG2a, an unidentified 
peptide with a protonated molecular mass of 2839.0 
was found in peak 26 (Figure 6). The corresponding 
peak at m/z 2837.7 also was found in MALDI/TOF-MS 
analysis. It was proposed that this mass value could 
correspond to the protonated molecular ion of the 
peptide T’hr120H-Lys147H, because the expected mass 
for this peptide could not be observed either in 
MALDI/TOF-MS or LC/ESI-MS analyses of the lysyl- 
endopeptidase digest. After isolation of this peptide, it 
was subjected to sequence analysis. A Ser residue was 
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1640.7 
67 
20 25 30 35 40 45 50 55 60 65 ‘O min. 
Figure 3. UV chromatogram obtained by capillary HPLC of the lysyl-endopeptidase digest of RCM 
IgGl and an ES1 mass spectrum of peak 62. 
found instead of Thr136H. As in the case of IgGl, the 
difference in the triplet codon for Ser and Thr is only 
the first letter in the triplet. Therefore, such substitu- 
tion could occur easily. The revised sequence of this 
peptide was confirmed by FAB mass spectrometry 
analysis, where the detection of monoisotopic proto- 
nated molecular ions was via a sector-type instrument. 
The existence of N-linked oligosaccharide at 
Asn297I-I in IgG2a also was confirmed in both 
MALDI/TOF-MS and LC/ESI-MS analyses of lysyl- 
endopeptidase and V8 protease digests. For example, 
glycopeptides 247H-317H and 249H-317H with sugar 
chain type E and F (and/or G) were observed in peak 
46 in Figure 6. The existence of the C-terminal Lys 
residue in IgG2a was identified in both MALDI/TOF- 
MS and LC/ESI-MS of the lysyl-endopeptidase digest 
of RCM IgG2a:The C-terminal peptide 440H-446AH 
was found in peak 5 in Figure 6 at m/z 376.0 (2 + > 
and 751.1 (l+ 1. Only the C-terminal peptide that has 
Lys446AH at the C-terminal of the heavy chain was 
found in LC/ESI-MS analysis. The established se- 
quence of IgG2a is indicated in Figure 5. 
We observed that the C-terminal Lys of the heavy 
chain of IgG2a is missing when the IgG2a hybridoma 
cells are cultivated in mouse ascites (data not shown) 
and that the C-termini of the heavy chain are variable 
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181H-210H? 
3121.0 
148H-1 S8H 
1295.7 
159H-180) 
218O.e 
1 
r: 
148H-21 OH 
8580.2 
1 
35 40 45 50 55 60 65 min. 
Figure 4. LJV chromatogram obtained by capillary I-TLC of the 
chymotryptic digest of peak 62 in Figure 3. The number on each 
peak indicates the protonated molecular mass of the peptide 
contained in the peak. 
in the mouse switch variant IgGs that is prepared in 
the same manner. In addition, the length of the amino 
acid sequences of IgG2a is different for those produced 
by the mouse cell culture (in vitro) and those produced 
in mouse ascites (in viva). The variation of the C- 
terminus of the heavy chain in the switch variant 
IgG2a and IgG2a(s) also was studied by NMR [291; the 
results obtained here are consistent with those ob- 
tained by NMR. 
The amino acid sequence of IgG2a(s), in which the 
C,l domain is deleted from IgG2a, was identical 
to the expected sequence 121, 221 except for the C- 
terminal Lys residue. The Lys residue at the C-terminus 
of the heavy chain of IgG2a(s) is absent in the majority 
of the population. A peptide Se&OH-Lys446AH with 
protonated molecular mass of 750.4 was found during 
LC/ESI-MS analysis of the lysyl-endopeptidase digest. 
As is the case of IgG2a, glycopeptides with an N-linked 
sugar chain were observed in LC/ESI-MS and 
MALDI/TOF-MS analyses. In LC/ESI-MS of the lysyl- 
endopeptidase digest of RCM IgG2a(s), molecular 
masses of 9700.8, 9296.4, and 9548.8 were observed in 
the deconvoluted spectra. These peaks correspond to 
glycopeptides 249H-317I-l with oligosaccharide type F 
(and/or G) and 247H-317H with oligosaccharide type 
E and F (and/or G). The established sequence of 
IgG2a(s) is summarized in Figure 5. 
In the case of IgG2b, five sequences that carry 
allotype-a were reported for the constant region of the 
heavy chain [20,22-261. In the IgG2b studied here, no 
substitution of the amino acid residue was found com- 
pared to a reference sequence [22, 251, which is identi- 
cal to Figure 5, except for the absence of the C-terminal 
Lys residue. The existence of the C-terminal Lys residue 
of the heavy chain in IgG2b could not be identified by 
MALDI/TOF-MS and capillary-LC/ESI-MS analyses. 
All the C-terminal peptides observed in the analyses 
lacked Lys446AI-I. For example, the component of mass 
716.6 in the deconvoluted spectrum in LC/ESI-MS 
corresponds to the peptide 440H-446H, with no Lys 
residue. The existence of N-linked oligosaccharides has 
been confirmed also in IgG2b. Type E, F (and/or G), 
and H sugar chains could be recognized in either 
LC/ESI-MS or MALDI/TOF-MS of the digests. For 
example, molecular weights of glycopeptides 259H- 
317H with sugar chain E, F (and/or G), and H were 
recognized in LC/ESI-MS of lysyl-endopeptidase di- 
gest of RCM IgG2b as 8256.0, 8418.0, and 8583.0, re- 
spectively, in the deconvoluted spectra. 
In addition, the existence of O-linked oligosaccha- 
rides was verified by capillary LC/ESI-MS analysis of 
the lysyl-endopeptidase digest of RCM IgG2b in the 
present study. Previous reports claimed that about 
40% of the populations of IgG2b had O-linked 
oligosaccharides at ThrZlAH, whereas about 60% of 
the populations do not possess O-linked oligosaccha- 
ride [30]. The expected molecular weights of two O- 
glycosylated peptides Lys214H-Lys228H generated by 
lysyl-endopeptidase digestion are calculated to be 
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376.0 
28 
I..., ,,~,~,..,..,,,....,~,..,,,............,,,.,.....~.,,,, 
30 40 50 60 70 80 min. 
Figure 6. UV chromatogram obtained by capillary HPLC of the lysyl-endopeptidase digest of RCM 
IgGPa and ES1 mass spectra of peak 5,26, and 46. 
2977.2 (average) and 2961.2 (average), whereas that of 
a nonglycosylated peptide can be calculated to be 
1997.3 (average) (1996.0; monoisotopic). The relative 
content of these three peptides has been reported as 35, 
4, and 60%, respectively [30]. In LC/ESI-MS of the 
lysyl-endopeptidase digest of RCM IgG2b a nonglyco 
sylated and an 0-glycosylated peptide with molecular 
weights of 1996.2 and 2977.0 were observed. However, 
it was impossible to observe the other 0-glycosylated 
peptide with molecular weight 2959.3, probably due to 
the very small amount of this component. 
Relationships between the Serological Properties and 
the Structures of Allolypic Markers 
Figure 7 shows a space-filling model of the Fab region 
of human IgGl (PDB code 2IG2). The position 136H, at 
which amino acid substitution exists in the case of 
IgG2a, is indicated in red. Ser136H, which exists on the 
surface of the Cr.,1 domain and is exposed to solvent, 
is facing the C, domain and is close to the hinge 
region. In the case of IgGl produced by haplotype-j 
mice, substitutions of two amino acid residues, 
Thr193H and Trp194H, have been identified in this 
study. Amino acid residues at positions of 193H and 
194H are indicated in green in Figure 7. Contrary to 
the case of IgG2a, these amino acids seem to be buried 
inside the structure. 
It has been reported that allotypic markers for allo- 
type-a and allotype-j of mouse IgG2a are located in the 
Fab fragment. However, amino acid residues that corre 
spond to these allotypic markers have not been identi- 
fied yet [14]. It is possible that Ser136H in the Fab of 
IgG2a is related to the allotypic marker of allotype-j, 
although the structural difference between Ser and Thr 
residues is not so remarkable. If Ser136H is related to 
the allotypic markers of allotype-j, it is reasonable that 
the amino acid residue at 136H is located on the 
surface of the molecule and allotype-a and -j of IgG2a 
can be distinguished only by a special guinea pig 
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Figure 7. Space-filling model of the Fab region of human IgGl. The atomic coordinates of the 
immunoglobulin molecule were obtained from the Protein Data Bank (code 2IG2). The model was 
generated by using the program BIOCES. The V, and C,l domains along with the hinge region are 
indicated in yellow. The V, and C, domains are indicated in blue. Ser137H in the heavy chain is 
indicated in red. Amino acid residues at 193H and 194H in the heavy chain are indicated in green. 
antiserum. On the other hand, it is also quite possible 
that the structural differences in IgGl cannot be distin- 
guished by any antisera. 
Characteristics of Mass Spectrometric Techniques 
in the Structural investigation of Large Biological 
Molecules 
Since its development, MALDI/TOF-MS often has been 
used for peptide mapping of proteins [l, 2, 31, 321. 
Molecular weights of all the target proteins in these 
studies were less than 60,000. Consideration of previ- 
ous and current results allows us to conclude that 
MALDI/TOF-MS is effective for peptide mapping of 
proteins with a molecular weight of less than 60,000. 
However, other supplementary analytical methods are 
required to complete the characterization of the struc- 
ture of larger molecules. It is impossible to observe all 
the molecular ions of digested peptides in a single 
MALDI/TOF mass spectrum, even if several kinds of 
matrices are applied. 
In the present work, LC/ESI-MS analysis was used 
. 720. AKASHl ET AL. 
for supplementary characterization of the sequences of 
IgGs. Assignments of molecular mass values to the 
peptides observed in capillary ES1 mass spectra were 
achieved by comparison with the results detected in 
MALDI/TOF-MS. The results obtained by MALDI/ 
TOF-MS peptide mapping facilitated the assignment of 
the observed mass values in LC/ ESI-MS to the pep- 
tides, even if only one peak could be observed in the 
ES1 mass spectrum and the deconvolution procedure 
was not successful. Accordingly, the assignment of the 
mass values observed in ESI-MS to the pepides was 
not difficult to perform. 
In the present study, reduction and carboxymeth- 
ylation were carried out before the structural investi- 
gation and the antibodies were transformed into four 
polypeptides: two RCM light chains with mass of 25 
ku and two RCM heavy chains with mass of 51 ku [41 
ku in the case of IgGZa(s)]. Accordingly, the molecular 
weights of the proteins dealt with in this study are 
actually less than 80 ku. The techniques and strategies 
used in the present work also can be applied to pro- 
teins with molecular weights of 80 ku or more. In 
addition, although the number of peptides derived 
from the enzymatic digestion increases as the molecu- 
lar weight of the protein increases, the molecular 
weight of the peptides can be determined by the same 
strategy used here. 
Conclusion 
We have confirmed that the amino acid sequences of 
the V,, V,, and C, regions are identical in all the 
switch variant IgGs. Several amino acid substitutions 
in the C,l domain of IgGl and IgG2a compared to the 
reference sequences were detected in this study. The 
existence of an allotypic marker on IgG2a was sug- 
gested in the C,l domain. 
The peptide mapping of a large protein such as IgG 
revealed that MALDI/TOF-MS is not as effective as it 
is in the case of a protein with molecular weight of less 
than 60,000. This situation limits the application of 
MALDI/TOF-MS for peptide mapping: if too many 
peptides are generated by the digestion, it is difficult 
to detect all of them in a single MALDI/TOF mass 
spectrum. Capillary LC/ESI-MS was revealed to be 
more effective for the characterization of IgGs. 
This study shows that amino acid sequences of 
proteins such as IgG can be investigated without infor- 
mation about the corresponding DNA sequence if it is 
possible to use appropriate reference sequences de- 
rived from other strains. In addition, the precise se- 
quence analyses of IgGs make it possible to discuss the 
relationship between the structure and serological 
properties that is difficult to determine without mass 
spectrometry analyses. 
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